Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers
Status
Conditions
Treatments
Details and patient eligibility
About
The nutrient composition of this product is similar to the existing Liquid IV "hydration multiplier" product already on the market but with the addition of amino acids. With such low quantities of amino acids, in particular as compared to the amounts consumed in normal diets, there is no reason to believe that the product would cause any adverse outcomes. However, since no research has been done on the safety of regular consumption of this product, this study will evaluate the safety of the product with regards to routing blood chemistries and other variables. Specifically, standard testing will be performed including a measurement of vital signs, comprehensive metabolic panel, hematology panel, urinalysis, and quantification of triiodothyronine, thyroxine, and thyroid stimulating hormone. A questionnaire will also be used to assess product tolerability.
Full description
Maintaining adequate hydration is essential to optimal health, as well as athletic performance. When individuals exercise (in particular in a warm environment), they can lose excessive amounts of fluids along with necessary electrolytes (e.g., sodium, potassium, chloride) through sweating. With dehydration, individuals may feel sluggish and can experience impaired physical performance.
The use of electrolytes (sodium in particular) has been used for decades to aid athlete hydration and has led to the development of various sport drinks (e.g., Gatorade, Powerade) -which also include small amounts of carbohydrate. The addition of amino acids to electrolyte solutions has previously been demonstrated to further increase the transport of water and sodium from the jejunum (small intestine). Separate research also showed an amino acid and electrolyte drink increased cellular hydration compared to flavored water and electrolyte only drinks. A 2019 study found that amino acids hydration increased beverage hydration index (BHI)-a measure of fluid balance following consumption of a beverage and was age dependent.
Amino acids supplementation has been popular for some time among athletes due to other potential performance benefits including changes to anabolic hormone levels, alterations to energy consumption, and mental endurance. Further, amino acids may reduce post-exercise muscle soreness and aid in recovery.
The electrolyte amino-acid test product is a powder provided in individual stick packs and contains L-Alanine and L-Glutamine as well as 5 essential vitamins including Vitamins B3, B5, B6, B12 and Vitamin C. It is gluten-, soy-, and dairy-free, and provides electrolytes well below the daily value. The daily value (DV) tells us how much a particular nutrient in a serving of a food product contributes to a daily diet, based on a standard 2000 calorie diet. Despite what the name suggests, this product is taken orally, not intravenously. Liquid IV packets contain: sodium (510 mg, 22%DV) and potassium (380 mg, 8%DV). These packets contain a small percentage of the needed total electrolytes but adequate amounts to replace lost electrolytes as a result of physical activity.
The nutrient composition of this product is similar to the existing Liquid IV "hydration multiplier" product already on the market but with the addition of amino acids. With such low quantities of amino acids, in particular as compared to the amounts consumed in normal diets, there is no reason to believe that the product would cause any adverse outcomes. However, since no research has been done on the safety of regular consumption of this product, this study will evaluate the safety of the product with regards to routing blood chemistries and other variables. Specifically, standard testing will be performed including a measurement of vital signs, comprehensive metabolic panel, hematology panel, urinalysis, and quantification of triiodothyronine, thyroxine, and thyroid stimulating hormone. A questionnaire will also be used to assess product tolerability.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Body mass index (BMI) between 18-29.9 kg/m2
- able to fast overnight
Exclusion criteria
- tobacco user
- history of heart disease/cardiovascular disease
- hypertensive (140/90 mmHg or less)
- diabetes
- history of immune disorder
- history of kidney disease
- hepatic impairment or disease
- history of unstable thyroid
- abnormality or obstruction of the gastrointestinal tract precluding swallowing
- abnormal digestion conditions
- previously diagnosed major affective disorder
- psychiatric disorder that required hospitalization in prior year
- history of cancer (except localized skin cancer without metastases or in situ cervical cancer within 5 years prior to screening)
- no known sensitivity or allergy to any of the study products
- consumption of alcohol-containing beverages within 24 hours of testing
- consumption of caffeine-containing beverages within 24 hours of testing
- active infection or illness of any kind
- if female, lactating, pregnant, or planning to become pregnant during the study
- receipt or use of an investigational product in another research study or change in medication, dietary supplementation, or significant change in diet/exercise regimen within 28 days prior to baseline/visit 2
Trial design
Primary purpose
Allocation
Interventional model
Masking
40 participants in 4 patient groups, including a placebo group
Trial contacts and locations
Loading...
Central trial contact
Jacquelyn Pence, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal